Archives of Medical Research
Volume 40, Issue 6 , Pages 443-448 , August 2009

Immunobiology of HPV Infection

  • Rodolfo Garcia-Chacon

      Affiliations

    • Departamento de Biología Celular, Cinvestav-IPN, México D.F., México
    • ,
  • Sandra Fabiola Velasco-Ramirez

      Affiliations

    • Departamento de Fisiología, Centro Universitario de Ciencias de la Salúd, Universidad de Guadalajara, Guadalajara, Jalisco, México
    • ,
  • Leopoldo Flores-Romo

      Affiliations

    • Departamento de Biología Celular, Cinvestav-IPN, México D.F., México
    • Corresponding Author InformationAddress reprint requests to: Leopoldo Flores-Romo, Departamento de Biología Celular, Cinvestav-IPN, Av. IPN No. 2508, Zacatenco CP 07360, México D.F., México
    • ,
  • Adrián Daneri-Navarro

      Affiliations

    • Departamento de Fisiología, Centro Universitario de Ciencias de la Salúd, Universidad de Guadalajara, Guadalajara, Jalisco, México

Received 14 May 2009 ,Accepted 18 May 2009.

References 

  1. Ll Quintana-Murci, Alcaïs A, Abel L, et al. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat Immunol. 2007;8:1165–1171
  2. Quayle AJ, Poter EM, Nussbaum AA, et al. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol. 1998;152:1247–1258
  3. Sharif K, Olufowobi O. The structure, chemistry and physics of human cervical mucosa. In:  Jordan J,  Singer A,  Jones HW,  Shafi MI editor. The Cervix. 2nd ed. Oxford UK: Blackwell Publishing; 2006;p. 157–168
  4. Nikolaitchouk N, Andersch B, Falsen E, et al. The lower genial tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH). APMIS. 2008;116:263–277
  5. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008;453:620–625
  6. Ley RE, Lozupone CA, Hamady M, et al. Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Microbiol. 2008;6:776–788
  7. Schaefer TM, Fahey JV, Wright JA, et al. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist Poly(I:C). J Immunol. 2005;174:992–1002
  8. Aflatoonian R, Tuckerman E, Elliott SL, et al. Menstrual cycle-dependent changes of Toll-like receptors in endometrium. Hum Reprod. 2007;22:586–593
  9. O'Neill LAJ. Toll-like receptors in cancer. Oncogene. 2008;27:158–160
  10. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol. 2008;8:259–268
  11. Waldhauer I, Steinle A. NK cells and cancer immunosurveillance. Oncogene. 2008;27:5932–5943
  12. Moretta L, Bottino C, Pende D, et al. Surface NK receptors and their ligands on tumor cells. Semin Immunol. 2006;18:151–158
  13. Textor S, Durst M, Jansen L, et al. Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. Int J Cancer. 2008;123:2343–2353
  14. Arreygue-Garcia NA, Daneri-Navarro A, del Toro-Arreola A, et al. Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions. BMC Cancer. 2008;8:16
  15. Albarran-Somoza B, Franco-Topete R, Delgado-Rizo V, et al. CEACAM1 in cervical cancer and precursor lesions: association with human papillomavirus infection. J Histochem Cytochem. 2006;54:1393–1399
  16. Jimenez FR, Mendez CR, Ojeda OJ, et al. High-risk human papillomavirus infection decreases the frequency of dendritic Langerhan's cells in the human female genital tract. Immunology. 2005;117:220–228
  17. García G, Pedroza A, Aguilar D, et al. Airways infection with virulent Mycobacterium tuberculosis delays the influx of dendritic cells and the expression of costimulatory molecules in mediastinal lymph nodes. Immunology. 2004;112:661–668
  18. Flores LA, Meza PS, Calderon AJ, et al. Network of dendritic cells within the muscular layer of the mouse intestine. PNAS. 2005;102:19039–19044
  19. Limon-Flores AY, Perez-Tapia M, Estrada-Garcia I, et al. Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int J Exp Pathol. 2005;86:323–334
  20. Stanley MA. Immunochemistry and immunology of the cervix. In:  Jordan J,  Singer A,  Jones HW,  Shafi MI editor. The Cervix. 2nd ed. Oxford UK: Blackwell Publishing; 2006;p. 49–61
  21. Das K, Burday M, Heller DS. Pathology of inflammatory disease of the cervix. In:  Jordan J,  Singer A,  Jones HW,  Shafi MI editor. The Cervix. 2nd ed. Oxford UK: Blackwell Publishing; 2006;p. 209–230
  22. Friedell GH, Hertig AT, Younge PA. Carcinoma. In: Situ of the Uterine Cervix. Springfield: Charles C Thomas; 1960;
  23. Underwood CI. The ultrastructure of the local cellular reaction to neoplasia. In:  Bourne EGH,  Denielli JF editor. International Review of Cytology. New York: Academic Press; 1974;
  24. Marais D, Constant D, Allan B, et al. Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women. J Clin Microbiol. 2008;46:732–739
  25. Lehtinen M, Pawlita M, Dillner MJ, et al. Evaluation of antibody response to human papillomavirus early proteins in woman whom cervical cancer developed 1–20 years later. Am J Obstet Gynecol. 2003;188:49–55
  26. Bard E, Riethmuller D, Meillet D, et al. High-risk papillomavirus infection is associated with altered antibody responses in genital tract: non-specific responses in HPV infection. Viral Immunol. 2004;17:381–389
  27. Neguye HH, Broker TR, Chow LT, et al. Immune responses to human papillomavirus in genital tract of women with cervical cancer. Gynecol Oncol. 2005;96:452–461
  28. Nardelli-Haefliger D, Wirthner D, Schiller J, et al. Specific antibody levels at the cervix during menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Institute. 2003;95:1128–1129
  29. Marais D, Sampson C, Jeftha A, et al. More men than women make mucosal IgA antibodies to human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population. BMC Infect Dis. 2006;6:95
  30. Yeaman GR, Guyre PM, Fanger MW, et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol. 1997;61:427–435
  31. White H. Proceeding Annual Meeting of the American Society for Reproductive Immunology; June 26; Knoxville, TN. Oxford, UK: Blackwell Publishing; 1996;
  32. Frazer IH. Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol. 2004;4:46–54
  33. Connor J, Ferrer K, John P, et al. Evaluation of Langerhans cells in the cervical epithelium of women with cervical intraepithelial neoplasia. Gynecol Oncol. 1999;75:130–135
  34. Hopfl R, Heim K, Christensen N, et al. Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 onco-protein E7. Lancet. 2000;356:1985–1986
  35. Kadish A, Timmins P, Wang Y, et al. Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomark Prevent. 2002;11:483–488
  36. Höhn H, Pilch H, Günzel S, et al. Human papillomavirus type 33 E7 peptides presented by HLA-DR∗0402 to tumor-infiltrating T cells in cervical cancer. J Virol. 2000;74:6632–6636
  37. Daneri-Navarro A, Del Toro-Arreola S, Sanchez-Hernandez PE, et al. Immunosuppressive activity of proteases in cervical carcinoma. Gynecol Oncol. 2005;98:111–117
  38. Daneri-Navarro A, Del Toro-Arreola S, Bravo-Cuellar A, et al. Proteolytic activity in extracts of invasive cervical carcinoma and precursor lesions. Biomed Pharmacother. 1995;49:304–310
  39. Borchers A, Braspenning J, Meijer J, et al. E7-specific cytotoxic T cell tolerante in HPV-transgenic mice. Arch Virol. 1999;144:1539–1556
  40. Reid SW, McAdam S, Smith KJ, et al. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med. 1996;184:2279–2286

PII: S0188-4409(09)00084-8

doi: 10.1016/j.arcmed.2009.05.003

Archives of Medical Research
Volume 40, Issue 6 , Pages 443-448 , August 2009

Article Tools